EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Novel 2-Substituted Aniline Pyrimidine Based Derivatives as Potent Mer/c-Met Dual Inhibitors with Improvement Bioavailability

Jixia Yang, Daowei Huang, Ruojin Wang, Pengxin Fan, Rourou Li, Donglai Ma iD

Biomolecules · 2025

DOI: 10.3390/biom15081180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Jixia Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China. Hauptthemen laut MEDLINE: Aniline Compounds, Pyrimidines, Protein Kinase Inhibitors, Receptor Protein-Tyrosine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Research Project of Hebei Education Department, College Students' Innovation and Entrepreneurship Training Program, Special Project for Basic Research Business Expenses of Provincial Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study reports the rational design and systematic evaluation of a novel series of 2-substituted aniline pyrimidine derivatives as dual Mer/c-Met inhibitors. Among the synthesized compounds, 17c demonstrated potent dual kinase inhibition, with IC50 values of 6.4 ± 1.8 nM (Mer) and 26.1 ± 7.7 nM (c-Met). The compound exhibited significant antiproliferative activity across multiple cancer cell lines (HepG2, MDA-MB-231, and HCT116), while showing minimal hERG channel inhibition (IC50 > 40 μM), indicating favorable cardiac safety. Pharmacokinetic profiling revealed high metabolic stability in human liver microsomes (t1/2 = 53.1 min) and moderate oral bioavailability (F: 45.3%), with strong plasma protein-binding affinity (>95%). Mechanistic studies further demonstrated that 17c dose-dependently suppressed HCT116 cell migration and induced apoptosis. These integrated pharmacological properties position 17c as a promising therapeutic candidate for dual Mer/c-Met drive malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aniline CompoundsPyrimidinesProtein Kinase InhibitorsReceptor Protein-Tyrosine KinasesMolecular StructureLigandsMolecular Docking SimulationHumansAnimalsCricetinaeCHO CellsCricetulusMicrosomes, LiverStructure-Activity RelationshipCell ProliferationApoptosisBiological AvailabilityProto-Oncogene Proteins c-met

Stichwörter der Autor:innen

2-substituted aniline pyrimidineMer kinaseMer/c-Met dual inhibitoranti-cancerc-Met kinase

Substanzen

anilineAniline CompoundsPyrimidinesLigandsProtein Kinase InhibitorsReceptor Protein-Tyrosine KinasesProto-Oncogene Proteins c-met

Autor:innen und Institutionen

  • School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.

ORCID-Profile: Donglai Ma

Förderung

  • Science Research Project of Hebei Education Department
  • College Students' Innovation and Entrepreneurship Training Program
  • Special Project for Basic Research Business Expenses of Provincial Universities
  • Doctoral Research Fund Project
  • National Natural Science Foundation of China
  • College Students’ Innovation and Entrepreneurship Training Program

Zitieren

APA

Yang, J., Huang, D., Wang, R., Fan, P., Li, R., & Ma, D. (2025). Discovery of Novel 2-Substituted Aniline Pyrimidine Based Derivatives as Potent Mer/c-Met Dual Inhibitors with Improvement Bioavailability. Biomolecules. https://doi.org/10.3390/biom15081180

Vancouver

Yang J, Huang D, Wang R, Fan P, Li R, Ma D. Discovery of Novel 2-Substituted Aniline Pyrimidine Based Derivatives as Potent Mer/c-Met Dual Inhibitors with Improvement Bioavailability. Biomolecules. 2025. doi:10.3390/biom15081180

BibTeX
@article{Yang2025,
  author = {Yang, Jixia and Huang, Daowei and Wang, Ruojin and Fan, Pengxin and Li, Rourou and Ma, Donglai},
  title = {Discovery of Novel 2-Substituted Aniline Pyrimidine Based Derivatives as Potent Mer/c-Met Dual Inhibitors with Improvement Bioavailability},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15081180}
}
Kostenlos starten →